- Report
- July 2023
- 100 Pages
Africa
From €1895EUR$2,000USD£1,599GBP
- Report
- January 2025
- 132 Pages
Global
From €900EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €900EUR$950USD£760GBP
- Report
- February 2022
- 132 Pages
Global
From €805EUR$850USD£680GBP
- Book
- January 2012
- 123 Pages
- Report
- November 2021
- 270 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- November 2021
- 365 Pages
Global
From €3317EUR$3,500USD£2,799GBP
- Report
- September 2022
- 265 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- August 2024
- 320 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- July 2024
- 216 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- July 2022
- 220 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- February 2022
- 229 Pages
Global
From €3517EUR$3,712USD£2,968GBP
- Book
- June 2024
- 496 Pages

The Microfluidics market within the Biotechnology sector is a rapidly growing field of research and development. It is focused on the manipulation of small volumes of fluids, typically in the range of nanoliters to microliters. This technology is used to create miniaturized systems for a variety of applications, such as drug delivery, diagnostics, and cell sorting. Microfluidics has the potential to revolutionize the way biotechnology is used in the medical, pharmaceutical, and industrial sectors.
The technology is used to create devices that can be used to analyze and manipulate biological samples, such as cells, proteins, and DNA. It can also be used to create miniature reactors for chemical synthesis and to develop new materials. Microfluidics has the potential to reduce the cost and complexity of many biotechnological processes.
Some of the leading companies in the Microfluidics market include Fluidigm, Bio-Rad Laboratories, Agilent Technologies, and Merck KGaA. These companies are developing a range of products and services to meet the needs of the biotechnology industry. Show Less Read more